Home > Press > FDA Needs to Systematically Collect Vital Nanotech Data, Attorney Says
Abstract:
Hundreds of nanotech products, including foods, medicines and medical devices, now have reached the market, and their number will grow exponentially in the years ahead. But the main regulatory body, the Food and Drug Administration, is not yet systematically collecting basic nanomaterial information, says John C. Monica, Jr., a partner at the law firm of Porter Wright Morris & Arthur LLP, in Washington, D.C, and head of the firm's nanotechnology practice group.
FDA Needs to Systematically Collect Vital Nanotech Data, Attorney Says
Washington, DC | Posted on February 20th, 2008
In an Insighter article, posted on the Food and Drug Law Institute's website, http://www.fdli.org/, Monica notes that FDA maintains that current laws and rules are probably adequate for most nanotechnology products regulated by the agency. But such issues of authority are overshadowed by an even more basic question of agency oversight, according to Monica, who writes: "To illustrate, try this: Place a general telephone call or email inquiry to FDA and ask whether the agency keeps a list of FDA-approved products employing nanoscale materials. Then dig deeper and call each of the six FDA centers (CDER, CFSAN, CBER, CVM, CDRH, and NCTR) and ask the same question. Unfortunately, no such list exists. In fact, FDA freely admits that it does not currently track this information."
Thus, Monica asserts, the larger question becomes whether the agency can appropriately react if a future problem is discovered related to the "nanoness" of one of its regulated products. Until the science is in, products using nanotechnology should be tracked and specifically monitored, concludes Monica. "FDA must be prepared to investigate whether other approved products might be susceptible to similar problems. The public will demand nothing less," says Monica, adding: "Right now, unfortunately, FDA does not even know which products contain nanoscale materials and has no definitive way of quickly making this determination."
The Food and Drug Law Institute's 1st Annual Conference on Nanotechnology Law, Regulation and Policy, co-sponsored by Woodrow Wilson International Center for Scholars Project on Emerging Nanotechnologies, in partnership with Burdock Group and Arizona State University, Feb. 28-29 in Washington, D.C., will focus on this and other important legal and regulatory issues concerning nanotechnology.
For more information on the conference, visit www.fdli.org/conf or contact Michael Levin-Epstein, Editor-in-Chief, (202) 222-0897 or
The full text of the Insighter piece is posted at www.fdli.org
####
About Food and Drug Law Institute
Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.
For more information, please click here
Contacts:
Michael Levin-Epstein
Editor-in-Chief
(202) 222-0897
Copyright © PR Newswire Association LLC.
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Govt.-Legislation/Regulation/Funding/Policy
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013
An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013
Discovery of new material state counterintuitive to laws of physics June 14th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Safety-Nanoparticles/Risk management
Further research on effects of nanomaterials: BASF participates in BMBF research project on safety of nanomaterials: Results allow easier and faster evaluation of nanoparticle behavior June 12th, 2013
Conference Scheduled June 5-7 on Safe Use of Nanotechnology in Environmental Remediation May 23rd, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Squishy hydrogels may be the ticket for studying biological effects of nanoparticles May 15th, 2013
Events/Classes
Research and industry frontrunners gather in Dublin at the EuroNanoForum, Europe’s largest nanotechnology conference June 18th, 2013
Discover the ‘Nanostructure Advantage’ at ECerS 2013, Booth 5: Innovnano presents nanostructured powders for high performance ceramics June 17th, 2013
SEMATECH to Address Critical Supply Chain Challenges and Present Latest Technology Advances at SEMICON West 2013 June 17th, 2013
Imec shows multiple enhancement options for next-generation FinFETs: Leading nano-electronics R&D center addresses key challenges of Germanium finFET technology at VLSI 2013 June 14th, 2013